Described herein are pharmaceutical packaging methods which protect against oxidative degradation of morphine, hydromorphone, promethazine along with other oxygen-sensitive medication, these programs together with a syringe having an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with quite small permeability to ox